Fauci Intelligence Community Release — page 70

UNCLASSIFIED UNCLASSIFIED 13 Aug 21 From: COMMANDANT OF THE MARINE CORPS FELLOW, DARPA To: INSPECTOR GENERAL Subj: SARS-CoV-2 ORIGINS INVESTIGATION WITH US GOVERNMENT PROGRAM UNDISCLOSED DOCUMENT ANALYSIS Ref:(1) Executive Slide HR00118Soo17 EcoHealth Alliance DEFUSE (2) HR00118S0017-PREEMPT-FP-019-PM Summary (Selectable - Not Recommended) (3) PREEMPT Volume 1 no ESS HR00118S0017 EcoHealth Alliance DEFUSE (4) PREEMPT Volume 2 EHA Final HR00118S0017 EcoHealth Alliance DEFUSE (5) SF424_2_0-V2.0 HR00118S0017 EcoHealth Alliance DEFUSE (6) WIV Budget packet HR001118S0017 EcoHealth Alliance DEFUSE (7) WS00094394-RR_KeyPersonExpanded_2_0-V2.0 HR001118S0017 EcoHealth Alliance DEFUSE (8) WS00094394-RR_PersonalData_1_2-V1.2 HR001118S0017 EcoHealth Alliance DEFUSE 1. SARS-CoV-2 is an American-created recombinant bat vaccine, or its precursor virus. It was created by an EcoHealth Alliance program at the Wuhan Institute of Virology (WIV), as suggested by the reporting surrounding the lab leak hypothesis. The details of this program have been concealed since the pandemic began. These details can be found in the EcoHealth Alliance proposal response to the DARPAi PREEMPTii program Broad Agency Announcement (BAA) HR00118S0017, dated March 2018iii - a document not yet publicly disclosed. The contents of the proposed program are extremely detailed. Peter Daszak lays out step-by-step what the organization intends to do by phase and by location. The primary scientists involved, their roles, and their institutions are indicated. The funding plan for the WIV work is its own document. The reasons why nonpharmaceutical interventions like masks and medical countermeasures like the mRNA vaccines do not work well can be extrapolated from the details. The reasons why the early treatment protocols work as curatives are apparent. SARS-CoV-2's form as it emerged is likely as a precursor, deliberately virulent, humanized recombinant SARSr-CoV that was to be reverse engineered into a live attenuated SARSr-Cov bat vaccine. Its nature can be determined from analysis of its genome with the context provided by the EcoHealth Alliance proposal. Joining this analysis with US intelligence collections on Wuhan will aid this determination. DEFENSE ADVANCED RESEARCH PROJECTS AGENCY 675 NORTH RANDOLPH STREET ARLINGTON, VA 22203-2114 For SHSGAC Use Only - SHSGAC_COVID_119th 011832